🔍 RecallPedia

💊

Prescription Drugs

💊 Drugs • 12,141 recalls

Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosphate 6 mg/mL PF Injection, Betamethasone Sodium Phosphate 8 mg/mL PF Injection, Betamethasone Sodium Phosphate 12 mg/mL PF Injection, manufactured by New England Compounding Center, Framingham, MA

New England Compounding Center

Class I - Dangerous

Lack of Assurance of Sterility

Sep 26, 2012 Prescription Drugs Nationwide View Details →

Methylprednisolone Acetate (PF) 80 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

New England Compounding Center

Class I - Dangerous

Non-Sterility

Sep 26, 2012 Prescription Drugs Nationwide View Details →

Methylprednisolone Acetate 80 mg/mL Injection, Preserved, supplied in 5 mL and 10 mL vials, manufactured by New England Compounding Center, Framingham, MA

New England Compounding Center

Class I - Dangerous

Non-Sterility

Sep 26, 2012 Prescription Drugs Nationwide View Details →

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

Abbott Laboratories

Class I - Dangerous

Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.

Dec 4, 2012 Prescription Drugs Nationwide View Details →

Cymevene 500 mg Powder for Infusion, (ganciclovir), 50 mg/mL ganciclovir (reconstructed), Rx only, 10 mL vials, Roche Products Limited, Welwyn Garden City, AL7 1TW, United Kingdom

F. Hoffmann-LaRoche

Class I - Dangerous

Lack of Assurance of Sterility; container closure issues with the bulk batch.

Sep 5, 2012 Prescription Drugs View Details →

Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

Lloyd Inc. of Iowa

Class I - Dangerous

Subpotent; 9-month stability interval

Jul 25, 2012 Prescription Drugs Nationwide View Details →

Levothroid (levothyroxine sodium tablets, USP), 50 mcg., 100-count bottles, Rx only, NDC 0456-1321-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

Lloyd Inc. of Iowa

Class I - Dangerous

Subpotent; 9-month stability interval

Jul 25, 2012 Prescription Drugs Nationwide View Details →

Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR

Alara Pharmaceutical

Class I - Dangerous

Subpotent; 15 month stability

Oct 29, 2012 Prescription Drugs Nationwide View Details →

Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA

Lloyd Inc. of Iowa

Class I - Dangerous

Subpotent; 9-month stability interval

Jul 25, 2012 Prescription Drugs Nationwide View Details →

Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

Lloyd Inc. of Iowa

Class I - Dangerous

Subpotent; 9-month stability interval

Jul 25, 2012 Prescription Drugs Nationwide View Details →

Procrit (epoetin alfa) injection, 20000 units/mL, 4 mL vial; Mfg By: Amgen Inc., Thousand Oaks, CA 91320; Dist. By: Physicians Total Care, Tulsa, OK 74146; NDC 54868-5673-1.

Physicians Total Care

Class I - Dangerous

Presence of Particulate Matter: glass delamination

Oct 4, 2010 Prescription Drugs View Details →

Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.

Watson Laboratories

Class I - Dangerous

Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.

Dec 13, 2012 Prescription Drugs Nationwide View Details →

CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, NDC 0004-0259-05; b) 120-count capsules per bottle, NDC 0004-0259-51; Made in Ireland; Distributed by: Genentech USA, Inc., South San Francisco, CA 94080.

Genentech

Class I - Dangerous

Short Fill: some bottles contained less than 120-count per labeled claim.

Sep 27, 2012 Prescription Drugs Nationwide View Details →

Choletec - Kit for the Preparation of Technetium Tc 99m Mebrofenin, 10 vials per box, Nonradioactive, Diagnostic Use, For Intravenous Use, Multidose, Rx Only, Manufactured for Bracco Diagnostics Inc. Princeton, NJ 08543, by Hollister-Stier Laboratories LLC, Spokane Washington 99207, NDC 0270-0083-20.

Bracco Diagnostic

Class I - Dangerous

Presence of Particulate Matter; potential for charcoal particulates

Aug 14, 2012 Prescription Drugs Nationwide View Details →

Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01

Hospira

Class I - Dangerous

Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.

Nov 21, 2012 Prescription Drugs Nationwide View Details →

Lidocaine HCl Injection, USP, 1% (10 mg/mL), 30 mL Single-dose Teartop Vial, packaged in 25-count vials per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-4279-02.

Hospira

Class I - Dangerous

Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.

Oct 4, 2012 Prescription Drugs Nationwide View Details →

Enjuvia (synthetic conjugated estrogens, B) tablets, 0.625 mg, 30-count tablets per bottle, Rx only, Mfg. By: Teva Pharmaceuticals USA, Sellersville PA 18960; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6163-1.

Physicians Total Care

Class I - Dangerous

Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

Apr 8, 2011 Prescription Drugs View Details →

Enjuvia (synthetic conjugated estrogens, B) tablets, 0.9mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6165-1.

Physicians Total Care

Class I - Dangerous

Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

Apr 8, 2011 Prescription Drugs View Details →

Enjuvia (synthetic conjugated estrogens, B) tablets, 0.3mg, 30-count tablets per bottle, Rx only, Mfg. By: Duramed Pharmaceuticals, Pomona NY 10970; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146; NDC 54868-6164-1.

Physicians Total Care

Class I - Dangerous

Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.

Apr 8, 2011 Prescription Drugs View Details →

Fluorouracil Topical Cream USP, 5%, 40 g Tube, Rx only, Mfd. by: Taro Pharmaceutical Industries, Ltd. Haifa Bay, Israel 26110, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4118-6.

Taro Pharmaceuticals U.S.A.

Class I - Dangerous

Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.

Nov 21, 2012 Prescription Drugs Nationwide View Details →

← Back to All Drugs Recalls